The present invention relates to the use of compounds from the group of 2-thia-dibenzo[e,h]azulenes and of their pharmacologically acceptable salts and solvates for the manufacture of a pharmaceutical formulation for the treatment and prevention of diseases, damages and disorders of the central nervous system (CNS) caused by disorders of the neurochemical equilibrium of biogenic amines or other neurotransmitters.
本发明涉及使用 2-
硫杂-二苯并[e,h]薁类化合物及其药理学上可接受的盐和溶解物制造药物制剂,用于治疗和预防因
生物胺或其他神经递质的神经
化学平衡失调而引起的中枢神经系统(CNS)疾病、损伤和紊乱。